138 related articles for article (PubMed ID: 15061753)
1. Quinolinic acid lesions of the caudate putamen in the rat lead to a local increase of ciliary neurotrophic factor.
Haas SJ; Ahrens A; Petrov S; Schmitt O; Wree A
J Anat; 2004 Apr; 204(4):271-81. PubMed ID: 15061753
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
[TBL] [Abstract][Full Text] [Related]
3. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.
McBride JL; Behrstock SP; Chen EY; Jakel RJ; Siegel I; Svendsen CN; Kordower JH
J Comp Neurol; 2004 Jul; 475(2):211-9. PubMed ID: 15211462
[TBL] [Abstract][Full Text] [Related]
4. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
de Almeida LP; Zala D; Aebischer P; Déglon N
Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
[TBL] [Abstract][Full Text] [Related]
6. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization.
Ferrante RJ; Kowall NW; Cipolloni PB; Storey E; Beal MF
Exp Neurol; 1993 Jan; 119(1):46-71. PubMed ID: 8432351
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
8. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
Emerich DF; Bruhn S; Chu Y; Kordower JH
Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
[TBL] [Abstract][Full Text] [Related]
9. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
Vazey EM; Chen K; Hughes SM; Connor B
Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
[TBL] [Abstract][Full Text] [Related]
10. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
[TBL] [Abstract][Full Text] [Related]
11. Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA- and kainic acid-induced neuronal death.
Honjo M; Tanihara H; Kido N; Inatani M; Okazaki K; Honda Y
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):552-60. PubMed ID: 10670488
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
Emerich DF; Winn SR
Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
[TBL] [Abstract][Full Text] [Related]
13. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
[TBL] [Abstract][Full Text] [Related]
14. γ-Aminobutyric acid type B receptor changes in the rat striatum and substantia nigra following intrastriatal quinolinic acid lesions.
Rekik L; Daguin-Nerrière V; Petit JY; Brachet P
J Neurosci Res; 2011 Apr; 89(4):524-35. PubMed ID: 21290407
[TBL] [Abstract][Full Text] [Related]
15. Ciliary neurotrophic factor overexpression in neural progenitor cells (ST14A) increases proliferation, metabolic activity, and resistance to stress during differentiation.
Weinelt S; Peters S; Bauer P; Mix E; Haas SJ; Dittmann A; Petrov S; Wree A; Cattaneo E; Knoblich R; Strauss U; Rolfs A
J Neurosci Res; 2003 Jan; 71(2):228-36. PubMed ID: 12503085
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
17. Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum.
Asada H; Ip NY; Pan L; Razack N; Parfitt MM; Plunkett RJ
J Neurosci Res; 1995 Jan; 40(1):22-30. PubMed ID: 7714923
[TBL] [Abstract][Full Text] [Related]
18. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
[TBL] [Abstract][Full Text] [Related]
19. Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease.
Scattoni ML; Valanzano A; Popoli P; Pezzola A; Reggio R; Calamandrei G
Behav Brain Res; 2004 Jul; 152(2):375-83. PubMed ID: 15196806
[TBL] [Abstract][Full Text] [Related]
20. Temporal profile of subventricular zone progenitor cell migration following quinolinic acid-induced striatal cell loss.
Gordon RJ; Tattersfield AS; Vazey EM; Kells AP; McGregor AL; Hughes SM; Connor B
Neuroscience; 2007 Jun; 146(4):1704-18. PubMed ID: 17459592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
